Fatty Liver: all 1,462 studies
Page 2 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University HospitalNot yet recruitingNCT06601361
- Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)RecruitingNCT06599918Phase 2
- Lifestyle Changes in Fatty Liver; Additive Effect of Honey IntakeRecruitingNCT06596109Not applicable
- Metabolic Syndrome and Fatty Liver Disease Among Egyptian Patients with Chronic HBVNot yet recruitingNCT06589167
- Synbiotics Impact on Insulin and TNF-α in MAFLD: a Gut Microbiota Profile AnalysisRecruitingNCT06585982Not applicable
- Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)RecruitingNCT06569524Phase 2
- Phase 2a Study of Safety, Tolerability, and Efficacy of TLC-2716 in Subjects With Hypertriglyceridemia and NAFLDRecruitingNCT06564584Phase 2
- Hepatic Mitochondrial Metabolism in Fatty Liver Disease in HumansEnrolling by invitationNCT06559878Not applicable
- GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver DiseaseNot yet recruitingNCT06546384Not applicable
- Positive Association of US-FLI With the Severity of CADRecruitingNCT06541132
- Ketogenic Diet in MASLD-related cACLDNot yet recruitingNCT06537466Not applicable
- Treatment and Handling Severe Obesity-Related Comorbidities in Adolescents Through ExerciseNot yet recruitingNCT06520800Not applicable
- Reducing Non-Alcoholic SteatohepatitisEnrolling by invitationNCT06519448Not applicable
- Study on the Correlation Between Fat Soluble Vitamins and Non-alcoholic Fatty Liver DiseaseRecruitingNCT06512701
- Free Walking Exercise in Obstructive Sleep Apnea Patients With Non-alcoholic Fatty LiverRecruitingNCT06508190Not applicable
- Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)RecruitingNCT06502834Phase 1
- Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver DiseaseRecruitingNCT06501326Phase 4
- Milk Thistle Clinical Trial in Pediatric NAFLDRecruitingNCT06477146Phase 2
- Multi-parametric Magnetic Resonance Imaging for the Precise Diagnosis and Quantitative Study of Liver Steatosis, Inflammation, and Fibrosis in Chronic Liver Disease.RecruitingNCT06463366
- HIBOC = Hepatic Imaging Biomarkers in Obese ChildrenEnrolling by invitationNCT06463223
- Frequency of Metabolic Dysfunction Associated Fatty Liver Disease in Patients With Acute Coronary SyndromesNot yet recruitingNCT06456970
- Assessment the Diagnostic Value of Pro-Neurotensin as a Serum Biomarker in MASLDNot yet recruitingNCT06453239
- Aronia and Non-alcoholic Fatty Liver DiseaseNot yet recruitingNCT06450769Not applicable
- Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLDRecruitingNCT06449833Phase 4
- Effects of Growth Hormone Therapy on Metabolic Function in Fatty Liver Post-Pituitary Adenoma SurgeryRecruitingNCT06448195Phase 4
- Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical ActivityNot yet recruitingNCT06446908Not applicable
- Perirenal Fats of Chronic Kidney Disease in Patients With Fatty Liver Disease.Not yet recruitingNCT06433388
- A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHRecruitingNCT06419374Phase 3
- Study of the Drivers of Late Diagnosis of Alcohol Related Diseases, Alone or in Combination With Metabolic Dysfunconal Associated Fatty Liver Disease, Implementation and Evaluation of Itnerventions to Reduce Its Burden.RecruitingNCT06403332Not applicable
- The Relationship Between Fatty Liver and Breast CancerRecruitingNCT06402084
- Safety of DNP007 in Healthy SubjectsRecruitingNCT06400771Phase 1
- Benefit of a Hospital Intervention in Patients with Hepatic SteatosisNot yet recruitingNCT06394206Not applicable
- Cardiac Dysfunction in Patients with Fatty Liver DiseaseRecruitingNCT06386094
- Comparison of MRI-PDFF to TAEUS FLIP Device to Estimate Liver Fat Fraction in AdultsNot yet recruitingNCT06373536
- Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）RecruitingNCT06368882Phase 4
- Human Models of Selective Insulin Resistance: Alpelisib, Part IRecruitingNCT06354088Phase 1
- High Fructose Diet, the Gut Microbiome, and Metabolic HealthRecruitingNCT06329544Not applicable
- Clinical Characteristics of Metabolic Associated Fatty Liver DiseaseRecruitingNCT06325254
- A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)RecruitingNCT06318169Phase 3
- Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With FibrosisRecruitingNCT06308757Not applicable
- Clinical Study Evaluating the Safety and Efficacy of Esomeprazole in Treatment of Non-alcoholic SteatohepatitisRecruitingNCT06302049Phase 1/2
- Efficacy Evaluation of Chang Geng Healthy Drink on Patients With Non-alcoholic Fatty Liver DiseaseNot yet recruitingNCT06266559Not applicable
- Different Exercise Modalities in the Treatment of NAFLD and Their Impact on MyokinesRecruitingNCT06257732Not applicable
- Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary SyndromeNot yet recruitingNCT06256289Phase 4
- Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Non-Alcoholic Fatty Liver Disease (PARADISE-NAFLD)RecruitingNCT06225713Not applicable
- Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk PopulationRecruitingNCT06225193
- Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver DiseaseNot yet recruitingNCT06218342Phase 4
- To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy SubjectsRecruitingNCT06216041Phase 1
- Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort StudyRecruitingNCT06211868
- Depletion of Liver Fat in Type 2 DiabetesRecruitingNCT06211556Not applicable
- Monitoring Changes in Hepatic Steatosis Using Continuous Controlled Attenuation ParameterRecruitingNCT06203548Not applicable
- A Multicenter, Double-blind, Placebo-randomized Controlled Clinical Study on the Treatment of Non-alcoholic Steatohepatitis With Tibetan Drug Langqing AtarRecruitingNCT06193629Not applicable
- Short Term Outcome of Metabolic Associated Fatty Liver Disease (MAFLD) in Patients Undergoing Bariatric SurgeryNot yet recruitingNCT06180928
- The Metabolic Effects of Ginseng Oligopeptide Preparation on Non- Alcoholic Fatty Liver Disease With Obesity: a Randomized Controlled Double-blind TrialNot yet recruitingNCT06167902Not applicable
- Elucidating Growth Hormone Dynamics at Stages of Progressive Nonalcoholic Fatty Liver DiseaseNot yet recruitingNCT06166797
- Study of Liver Fibrosis Stage Assessment by Fibroblast Activation Protein Imaging in Patients With Biopsy for Suspected or Proven Nonalcoholic SteatohepatitisNot yet recruitingNCT06160271Phase 2
- Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GNRecruitingNCT06157125
- Liver Fat and Glucagon ResistanceNot yet recruitingNCT06154096
- Clinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for EfficacyEnrolling by invitationNCT06152991Phase 3
- The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 DiabetesRecruitingNCT06144593Not applicable
- Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled TrialRecruitingNCT06138821Not applicable
- Study on MAFLD-related Cirrhosis Prevention and Treatment StrategiesNot yet recruitingNCT06135584Not applicable
- Association Betweenq MAFLD ( Metabolic Associated Fatty Liver Disease) and Chronic Kidney DiseaseNot yet recruitingNCT06135467
- Echocardiographic Findings as Markers of Subclinical Cardiac Dysfunction in Patients With Non-Alcoholic Fatty Liver DiseaseNot yet recruitingNCT06130202
- Kuwait Adult Diabetes Epidemiological Multidisciplinary (KADEM) ProgramRecruitingNCT06115876
- Effectiveness of Ultrasound in Liver Stiffness and Fat QuantificationRecruitingNCT06111859Not applicable
- Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA TrialRecruitingNCT06102980Not applicable
- Ultrasound Assessment of Sarcopenia in Patients With Chronic Liver Disease: the SARCOLIVER StudyRecruitingNCT06101758Not applicable
- Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFFNot yet recruitingNCT06097338
- UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)RecruitingNCT06080386
- Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort StudyRecruitingNCT06078722
- Effect of Thyroid Disorders in Liver DiseasesNot yet recruitingNCT06071923
- Liver Fat Content and Bariatric SurgeryRecruitingNCT06064240
- Effect of Timed-Restricted Eating on Metabolic HealthRecruitingNCT06061042Not applicable
- Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the USRecruitingNCT06051669
- Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 DiabetesRecruitingNCT06035874Not applicable
- Calisthenics Versus High Intensity Interval Training in NAFLRecruitingNCT06032650Not applicable
- The Role of Immune Semaphorins in Steatotic Liver Disease and SepsisRecruitingNCT06021743
- Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in AssiutNot yet recruitingNCT06009250
- Psoriasis and Non Alcoholic Steatohepatitis: Is There a Shared Inflammatory Network ?Not yet recruitingNCT05994677
- The Clock Thickens: Morning or Evening Training for the Treatment of NAFLD?Not yet recruitingNCT05987748Not applicable
- Effect of CoQ10 on the Outcome of MAFLD PatientsRecruitingNCT05984745Phase 2
- Association of HsCAR with MAFLD and Liver Fibrosis: a Cross-sectional StudyRecruitingNCT05974904
- Diet, Immunometabolism and Non-alcoholic Fatty Liver DiseaseRecruitingNCT05968378Not applicable
- Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)Not yet recruitingNCT05966025Phase 2
- Chronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.Enrolling by invitationNCT05956379Not applicable
- Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLDNot yet recruitingNCT05942963Phase 4
- the Efficacy and Safety of Diosmin on Non-diabetic Patients With Non-alcoholic Steatohepatitis.RecruitingNCT05942547Phase 3
- The Effect of Coenzyme Q10 on Endothelial, Vascular and Myocardial FunctionRecruitingNCT05941910Phase 2
- Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver DiseaseRecruitingNCT05913986Not applicable
- Cardio-Metabolic Risk Evaluation in Overweight and Obese ChildrenNot yet recruitingNCT05908877
- Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver DiseaseNot yet recruitingNCT05908006
- Omics Techniques in Fatty Liver DiseaseNot yet recruitingNCT05907408
- Transient Elastograghy to Detect Non Alcoholic Fatty Liver Disease in Renal Transplantation Recipients.Not yet recruitingNCT05894993
- Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight IndividualsRecruitingNCT05890365
- Preoperative Ketogenic Diet for Reduction of Hepatic SteatosisRecruitingNCT05884723Not applicable
- Prevalence of MAFLD Among Nurses and the Role of Intermittent FastingRecruitingNCT05880316Not applicable
- Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)RecruitingNCT05870969
- Relationship Between Heart Failure With Preserved Ejection Fraction and Nonalcoholic Fatty Liver Disease.Not yet recruitingNCT05822622
- Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic SteatohepatitisRecruitingNCT05821010Phase 2